SWIPHA receives Prequalification from WHO, meets NAFDAC’s Policy

Swipha is a Nigerian pharmaceutical company. It has received prequalification from the World Health Organization (WHO) for the production of sulfadoxine-pyrimethamine (SP), an effective medication for preventing malaria infection. As a manufacturer of drugs, the National Agency for Food and drugs administration and control (NAFDAC)  inspected the Swiss pharma plants  according to its recent policy […]